Gritstone Bio (NASDAQ: GRTS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Gritstone Bio (NASDAQ: GRTS) through any online brokerage.
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by HC Wainwright & Co. on Monday, May 9, 2022. The analyst firm set a price target for 12.00 expecting GRTS to rise to within 12 months (a possible 152.63% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Gritstone Bio (NASDAQ: GRTS) is $4.75 last updated August 16, 2022, 8:00 PM UTC.
There are no upcoming dividends for Gritstone Bio.
Gritstone Bio’s Q3 earnings are confirmed for Wednesday, November 2, 2022.
There is no upcoming split for Gritstone Bio.
Gritstone Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.